Obesity in people with fatty liver disease
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at how common obesity is in people with fatty liver disease (a condition where fat builds up in the liver). It aims to understand the relationship between these two conditions better, which might lead to improved care and prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with fatty liver disease by a doctor (through exams, blood tests, or imaging).
- You cannot be pregnant.
- You cannot have any active cancer.
- You cannot have type 1 diabetes.
- You must not be taking statins or other medications for fatty liver.
- You must not have had weight-loss surgery (bariatric surgery) in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a simple blood test (FIB-4) can help detect liver scarring in people with obesity. It may help doctors identify liver problems earlier.
This study looks at how fatty liver disease may predict future liver health in people with severe weight gain. It compares people who are planning bariatric (weight-loss) surgery with similar people who are not, to better understand who may be at higher risk.
This study looks at how nutrition and inflammation relate to a liver condition called MASLD (fatty liver disease). It aims to find patterns that may help guide better care for people with this condition.
This study looks at whether a hormone called leptin, which helps control hunger and body weight, is linked to a type of liver disease called MASLD (metabolic dysfunction-associated steatotic liver disease). It compares people with MASLD to healthy people to see if there's a difference. This could help doctors understand the condition better and find new ways to treat it.
This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.
This study uses multiple types of health data (“multi-omics”) to help choose a personalized treatment plan for people with obesity-related fatty liver disease. It may help match treatment to your biology to improve outcomes.
Hear when a new Lean MASLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.